Clinical practice protocol update in peritoneal dialysis-2004;Actualización de protocolos en la práctica clínica de diálisis peritoneal, año 2004

Nefrologia

Volumn 24, Issue 5, 2004, Pages 410-445

  Sansone, G ^a   Cirugeda, A ^a   Bajo, M A ^a   Del Peso, G ^a   Sanchez Tomero J A ^a   Alegre, L ^a   Hernandez Y ^a   Polanco, N ^a   Delgado Mallen P ^a   Soares, C ^a   Hevia, C ^a   Selgas, R ^a,b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CISAPRIDE; CLOXACILLIN; COTRIFAMOLE; COTRIMOXAZOLE; FLUCONAZOLE; GENTAMICIN; IMIPENEM; ISONIAZID; LEVOFLOXACIN; LINEZOLID; METOCLOPRAMIDE; METRONIDAZOLE; OFLOXACIN; OMEPRAZOLE; ONDANSETRON; PSEUDOMONIC ACID; RECOMBINANT ERYTHROPOIETIN; RHODOGIL; RIFAMPICIN; SURNOX; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN; VASODILATOR AGENT;

ABDOMINAL DISCOMFORT; ACID BASE BALANCE; ANEMIA; ARTICLE; CLINICAL PROTOCOL; COMORBIDITY; DRUG DOSE REGIMEN; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HEPATITIS; HEPATITIS A; HERNIA; HYPERCALCEMIA; HYPOCALCEMIA; INFLUENZA; INTESTINE PERFORATION; KIDNEY FUNCTION TEST; KLEBSIELLA; MENTAL FUNCTION; NAUSEA; NUTRITIONAL PARAMETERS; PAIN; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PROTEUS; PSEUDOMONAS; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SERRATIA; SEXUAL BEHAVIOR; STAPHYLOCOCCUS AUREUS; TETANUS; UREMIA; VOMITING;

CLINICAL PROTOCOLS; DIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PRACTICE GUIDELINES;

EID: 10044226417     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. R. Selgas, B. Miranda, F. Moreno y cols.: Diagramas de flujo en diálisis peritoneal continua ambulatoria (DPCA) Nefrología X: 15-27, 1990.
2. European Guidelines in Peritoneal Dialysis.
3. Up to date Vol. 11 No 2.
4. Curso Intensivo Teórico-Práctico de Formación Continuada en DIÁLISIS PERITONEAL Noviembre 2002-2003, Madrid.
5. Manual de Nefrología. Segunda Edición.
6. Textbook of Peritoneal Dialysis. Ram Cokal. Second Edition.
7. Normas de Actuación Clínica en Nefrología.
8. Nephrol Dial Transplant 17, Supl. 6, 2002.
9. Nephrol Dial Transplant 16, Supl. 3, 2001.
10. Nephrol Dial Transplant 14, Supl. 5, 1999. Guías Europeas para el manejo de la anemia en pacientes con IRC.
11. Robert Deicher, Walter H Hörl: Vitamin C for hyporesponsiveness to Epo: a cure for all? Am J Kidney Dis 42: 848-849, 2003.
12. DOKI Guidelines Am J Kidney Dis 30, 1997.
13. Ramón Paniagua, Dante Amato, Edward Vonesh y cols.: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX a prospective, randomised, controlled trial. J Am Soc Nephrol 13: 1307-1320, 2002.
14. Peter J. Margetts, David N. Churchill: Acquired ultrafiltration dysfunction in Peritoneal Dialysis patients. J Am Soc Nephrol 13: 2787-2794, 2002.
15. Sandro Alloatti, Massimo Manes, Giuseppe Paternoster y cols.: Peritoneal dialysis compared with hemodialysis in the treatment of end-stage renal disease. J Nephrol 13: 331-342, 2000.
16. Valderrábano F: Quality of life benefits of early anaemia treatment. Nephrol Dial Transplant 15: 23-28, 2000.
17. Anne B Bakewell, Rob M. Higgins, Mair E. Edmunds: Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes. Kidney Int 61: 239, 2002.
18. Terada I, Hyde C: The SF-36: an instrument for measuring quality of life in ESRD patients. EDTNA ERCA J 28: 73-6, 83, 2002.
19. Jung Ah Kim, Yung Kee Lee, Wooseong Huh y cols.: Analysis of depression in continuous peritoneal dialysis patients. J Koream Med Sci 17: 790-794, 2002.
20. Ram Gokal, Steven Alexander, Stephen Ash y cols.: Reviews and original articles. Peritoneal catheters and exit-site practices toward optimun peritoneal access: 1998 Update. Perit Dial Int 18: 11-33, 1998.
21. Ram Gokal, Steven Alexander, Stephen Ash y cols.: Reviews and original articles. Peritoneal catheters and exit-site practices toward optimun peritoneal access: 1998 Update. Perit Dial Int 18: 11-33, 1998.
22. Covadonga H, Bajo M, Aguilera A. y cols.: Alpha replacement method for displaced peritoneal catheter: a simple and effective maneuveur. Adv Per Dial 17: 138-141, 2001.
23. Lu CT, Watson DI, Elias TJ y cols.: Laparoscopic placement of peritoneal dialysis catheters: 7 years experience. ANZ J Surg 73: 109-111, 2003.
24. Tsimoyiannis EC, Siakas P, Glantzounis G y cols.: Laparoscopic placement of the Tenckhoff catheter for peritoneal dialysis. Surg Laparosc Endosc Percutan Tech 10: 218-221, 2000.
25. Miguela I, Lanuza M, Ruiz de Gauna M et al: Lower malfunction rate with self-locating catheters. Perit Dial Int 21:209-212, 2001.
26. Cavagna R, Tessarin C, Tarroni G y cols.: The self-locating catheter: clinical evaluation and comparison with the Tenckhoff catheter. Perit Dial Int 19: 540-543, 1999.
27. Di Paolo N, Petrini G, Garosi G y cols.: A new self-locating peritoneal catheter. Perit Dial Int 16: 623-627, 1996.
28. Hutchinson PJ, Chand DH: Use of tissue plasminogen activator in obstructed peritoneal dialysis catheters. Perit Dial Int 21, 2001.
29. Shea M, Hmiel SP, Beck AM: Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children. Adv Per Dial 17: 249-52, 2001.
30. Kim HJ, Lee TW, Ihm CG y cols.: Use of fluoroscopy-guided wire manipulation and/or laparoscopic surgery in the repair of malfunctioning peritoneal dialysis catheters. Am J Nephrol 22: 532-538, 2002.
31. van Guldener C, Robinson K.: Homocysteine and renal disease. Semin Thromb Hemost 26: 313-324, 2000.
32. Malyszko J, Malyszko JS, Hryszko T y cols.: Influence of simvastatin on aspects of thrombogenesis in CAPD patients. Perit Dial Int 23: 260-266, 2003.
33. Prichard S: Cardiovascular risk in peritoneal dialysis. Contrib Nephrol 82-90, 2003.
34. Hebert MJ, Falardeau M, Pichette V y cols.: Continuous ambulatory peritoneal dialysis for patients with severe left ventricular systolic dysfunction and end-stage renal disease. Am J Kidney Dis 25: 761-768, 1995.
35. Selgas R, Del Peso G, Bajo M y cols. Vascular endotelial growth factor (VEGF) levels in peritoneal dialysis effluent. J Nephrol 14: 270-274, 2001.
36. Selgas R, Bajo MA, Cirugeda A y cols.: Diagnóstico precoz, prevención y tratamiento de los síndromes esclerosantes peritoneales. Nefrología XXIII 38-43, 2003.
37. Parikova A, Machteld M. Zweers, Dirk Struijk G y cols.: Peritoneal effluent markers of inflammation in patients treated with Icodextrin-Based and Glucose-Based dialysis solutions. Adv Per Dial 19: 186-190, 2003.
38. Yánez-Mo M, Lara Pezzi E, Selgas R y cols.: Peritoneal dialysis and epithelial-to-mesenchymal transition to mesothelial cells. N Engl J Med 30: 403-413, 2003.
39. Tatjana Lilaj, Elisabeth Dittrich, Heidi Puttinger y cols.: A preceding exchange with polyglucose versus glucose solution modifies Peritoneal Equilibration Test results. Am J Kidney Dis 38: 118-126, 2001.
40. Ana E, Figueiredo A, Conti C, Poli de Figueiredo E: Influence of the preceding exchange on peritoneal equilibration test results. Adv Per Dial 18: 75-77, 2002.
41. An S. de Vriese and Norbert H. Lameire: Intravital microscopy: an integrated evaluation of peritoneal function and structure. Nephrol Dial Transplant 16: 657-660, 2001.
42. Lameire N, De Vriese A, Mortier S: Fisiopatología de la respuesta peritoneal a la diálisis. Intravital videomicroscopy in peritoneal dialysis research. Nefrología XXIII 28-31, 2003.
43. Selgas R, del Peso G, Bajo MA y cols.: El factor de crecimiento endotelial vascular (VEGF). Su papel en la fisiopatología peritoneal. Nefología XXI 423-425, 2001.
44. Selgas R, Del Peso G, Bajo MA y cols.: Vascular endotelial growth factor (VEGF) levels in peritoneal dialysis effluent. J Nephrol 14: 270-274, 2001.
45. Louise M Moist, Friedrich K Port, Sean M Orzol y cols.: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11: 556-564, 2000.
46. Gilles Hufnagel, Catherine Michel, Guillaume Queffeulou et al: The influence of automated peritoneal peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant 14: 1224-1228, 1999.
47. Richard J. Baker, Heather Senior, Michel Clemenger y cols.: Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 41, 2003.
48. Baczynski D, Antosiewicz S, Pietrzak B y cols.: Empirical therapy of peritonitis in peritoneal dialysis patients-it is reasonable to use a new therapeutic schedule? Pol Merkuriusz Lek 13: 396-398, 2002.
49. Douglas Shemin, Donna Maaz, Donna St. Pierre y cols.: Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 34: 14-20, 1999.
50. James F Medcalf, Kevin PG Harris, John Walls: Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 59: 1128, 2001.
51. Sug Kyun Shin, Hyunjin Noh, Shin Wook Kang et al: Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 19, 1999.
52. Jandeleit-Dahm K, Cao Z, Cox AJ et al: Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy. Kidney Int 71: 31-36, 1999.
53. Stefano Bianchi, Roberto Bigazzi, Alberto Caiazza et al: A controlled, prospective study of the effets of Atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis 41: 565-570, 2003.
54. Vijaya Venkataraman, Karl D Nolph: Preservation of residual renal function - An Important goal. Perit Dial Int 20: 392-395, 2000.
55. Francisco Coroneal, Beatriz Avilés: Chyloperitoneum in a peritoneal diálisis patient with Primary AL Amyloidosis. Perit Dial Int 23: 299-301, 2003.
56. Miguel Pérez Fontán, Ana Rodríguez-Carmona, Ignacio Galed et al: Incidence and significance of peritoneal eosinophilia during peritoneal dialysis-related peritonitis. Perit Dial Int 23: 460-464, 2003.
57. Yoshimoto K, Saima S, Nakamura Y et al: Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis. Clin Nephrol 50: 90-93, 1998.
58. Smith TA, Bailie GR, Eisele G: Chemical peritonitis associated with intraperitoneal vancomycin. DICP 25: 602-603, 1991.
59. Bargman JM, Zent R, Ellis P et al: Diagnosis of lymphoma in a continuous ambulatory peritoneal dialysis patient by peritoneal fluid cytology. Am J Kidney Dis 23: 747-750, 1994.
60. Peter Stenvinkel, Bengt Lindholm, Olof Heimbürger: New strategies for management of malnutritionin Peritoneal Dialysis patients. Perit Dial Int 20: 271-275, 2000.
61. James F. Winchester: L-Carnitine and peritoneal dialysis. Perit Dial Int 20: 150-153, 2000.
62. Robert Mushnick, Paul A Fein, Neal Mittman y cols.: Relationship of bioelectrical impedance parameters to nutrition and survival in peritoneal dialysis patients. Kidney Int 64: 53-56, 2003.
63. Terán-Estrada L y cols.: Evaluación nutricional en artritis Reumatoide. Rev Mex Reumat 17: 117-122, 2002
64. Gentilcore D, O'Donovan D, Jones KL y cols.: Nutrition therapy for diabetic gastroparesis. Curr Diab Rep 3: 418-426, 2003.
65. Amin K, Bastani B: Intraperitoneal Ondansetron hydrochloride for intractable nausea and vomiting due to diabetic gastroparesis in a patient on Peritoneal Dialysis. Perit Dial Int 22: 539-540, 2002.
66. Moss AH: Intraperitoneal metoclopramide improves symptoms of gastroparesis in CAPD patient. Perit Dial Int 9: 223-224, 1989.
67. Gallar P, Oliet A, Vigil A y cols.: Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dilaysis patients and the role of erythromycin. Perit Dial Int 13: 183-186, 1993.
68. Janssens J, Peeters TL, Vantrappen G y cols.: Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 12: 1028-1031, 1990.
69. Grzegorzewska AE, Mariak I: Zinc as a marker of nutrition in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 17: 223-229, 2001.
70. Aguilera A, Bajo MA, Del Peso G y cols.: True deficiency af antioxidant vitamins E and A in dialysis patients: relationship with clinical patterns of atherosclerosis. Adv Perit Dial 18: 206-211, 2002.
71. Jorge B Cannata-Andía, Minerva Rodríguez García: Hyperphosphatemia as a cardiovascular risk factor - how to manage the problem. Nephrol Dial Transplant 17: 16-19, 2002.
72. Naseem Amin: The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure. Nephrol Dial Transplant 17: 340-345, 2002.
73. Weinreich T, Ritz E, Passlick-Deetjen J: Long term dialysis with low-calcium solution (1.0 mmol/L) in CARD: effects on bone mineral metabolism. Perit Dial Int 16: 260-268, 1996.
74. Weinreich T, Passlick-Deetjen J, Ritz E: Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. Am J Kidney Dis 25: 452-460, 1995.
75. Merit F Gadallah, Neeru Arora, Carlos Torres y cols.: Pulse oral versus pulse intraperitoneal calcitriol: a comparison of efficacy in the treatment of hyperparathyroidism and renal osteodiystrophy in peritoneal dialysis patients. Adv Per Dial 16: 303-307, 2000.
76. Walter H Hörl: Renal Osteodystrophy: role of Calcimimetics. Am J Kidney Dis 41: 104-107, 2003.
77. Tadao Akizawa, Kazuhiro Shiizaki, Ikuji Hatamura y cols.: New strategies for the treatment of secondary hyperparathyroidism. Am J Kidney Dis 41: 100-103, 2003.
78. Geoffrey A Block, Friedrich K Port: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 35: 1226-1237, 2000.
79. Rodd Celia: Bisphosphonates in dialysis and transplantation patients: efficacy and safety issues. Perit Dial Int 21: 256-260, 2001.
80. Reslerova Martina, M Moe Sharon: Vascular calcification in dialysis patients: pathogenesis and consequences. Am J Kidney Dis 41: 96-99, 2003.
81. Coates T, Kirkland GS, Dymock RB y cols.: Cutaneous necrosis from calcific uremis arteriolopathy. Am J Kidney Dis 32: 514-518, 1998.
82. Rudwaleit M, Schwarz A, Trautmann C y cols.: Severe calciphylaxis in a renal patient on long-term oral anticoagulant therapy. Am J Nephrol 16: 344-348, 1996.
83. Sing Leung Lui, Fu Keung Li, Chi Yeun Lo y cols.: Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection. Adv Per Dial 16: 195-197, 2000.
84. Pérez-Fontán Miguel, Rosales Miguel, Rodríguez- Carmona Ana y cols.: Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 39: 337-341, 2002.
85. Nasal Mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin study group. J Am Soc Nephrol 17: 2403-2408, 1996.
86. Cheung AH, Wheeler MS, Limm WM y cols.: A salvage technique for continuous ambulatory peritoneal dialysis catheters with exit-site infections. Am J Surg 170: 60-61, 1995.
87. Tamas Szabo, Zeny Siccion, Sharron Izatt y cols.: Outcome of Pseudomonas aeruginosa exit-site and tunnel infections: a single center's experience. Adv Per Dial 15: 209-212, 1999.
88. Dapena F, Selgas R, García-Perea A y cols.: Clinical significance of exit-site infections due to Xanthomonas in CAPD patients: a comparison with Pseudomona infection. Nephrol Dial Transplant 9: 1774-1777, 1994.
89. Montenegro J, Saracho R, Aguirre R y cols.: Exit-site care with ciprofloxacin otologic solution prevents polyurethane catheter infection in peritoneal dialysis patients. Perit Dial Int 20: 209-214, 2000.
90. Cancho B, Garduno E, Domínguez C y cols.: Long-term results of an eradication regime against Staphylococcus aureus patients treated with peritoneal diálisis. Nefrología 21: 464-470, 2001.
91. Kleinpeter MA, Krane NK y cols.: Treatment of mycobacterial exit-site infections in patients on continuous ambulatory peritoneal dialysis. Adv Per Dial 17: 172-175, 2001.
92. William F Keane, George R Bailie, Elizabeth Boeschoten y cols.: Adult peritoneal dialysis-related peritonitis treatment. Recommendations: 2000 Update Perit Dial Int 20: 396-411, 2000.
93. John M Burkart: Microbiology and therapy of peritonitis in continuous peritoneal dialysis. Up to Date Vol. 11 N°2
94. Alberto Locatelli, M Álvarez Quiroga, L De Benedetti y cols.: Treatment of recurrent and resistant CARD peritonitis by temporary withdrawal of peritoneal dialysis without removal of the catheter. Adv Per Dial 11: 176-178, 1995.
95. Mrinal K Dasgupta: Strategies for intervention in and prevention of Biofilm-Related infection in Peritoneal Dialysis Patients. Adv Per Dial 19: 195-197, 2003.
96. Roland ME, Havlir DV: Responding to organ failure in HIV-Infected patients. N Engl J Med 5: 2279-2281, 2003.
97. Calabrese LH, Albrecht M, Young J: Successful Cardiac Transplantation in an HIV-1 Infected Patient with Advanced Disease. N Engl J Med 5: 2323-2328, 2003.
98. Jeffrey S. Berns, Jerome I Tokars: Preventing bacterial infections and antimicrobial resistance dialysis patients. Am J Kidney Dis 40: 886-898, 2002.
99. Adnan S Dajani, Kathryn A Taubert, Walter Wilson y cols.: Prevention of Bacterial Endocarditis: recommendations by the American Heart Association. Clinical Infectious Diseases 25: 1448-58, 1997.
100. Stephen Vas: The need for antibiotic prophylaxis during peritoneal dialysis. Perit Dial Int 19: 197-198, 1999.
101. Holmes CJ: Peritoneal host defense mechanims in peritoneal dialysis. Kidney Int 46: 58-70, 1994.
102. SI Vas, JM Bargman: Vaccination for peritoneal dialysis patients. Perit Dial Int 19: 115-116, 1999.